Australia Nucleic Acid Therapeutics Cdmo Market Size & Outlook

Name: Australia Nucleic Acid Therapeutics Cdmo Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The nucleic acid therapeutics cdmo market in Australia is expected to reach a projected revenue of US$ 915.5 million by 2033. A compound annual growth rate of 16% is expected of Australia nucleic acid therapeutics cdmo market from 2026 to 2033.

HC Outsourcing
- Clinical & Non-Clinical Outsourcing Services
  - Nucleic Acid Therapeutics CDMO Market Outlook

Australia nucleic acid therapeutics cdmo type outlook (Revenue, USD million, 2021-2033)
- Gene Therapy
- RNA-based Therapies
Australia nucleic acid therapeutics cdmo service outlook (Revenue, USD million, 2021-2033)
- Process Development and Optimization
- Manufacturing Services
- Analytical and Quality Control Services
- Others
Australia nucleic acid therapeutics cdmo end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical Companies
- Government & Academic Research Institutes
- Biotech Companies
Australia nucleic acid therapeutics cdmo application outlook (Revenue, USD million, 2021-2033)
- Rare Diseases
- Genetic Disorders
- Infectious Diseases
- Others

Australia Nucleic Acid Therapeutics Cdmo Market Size & Outlook

Data Tree

Sign up - it's easy, and free!